Volume 70, Issue 7, Pages 1318-1324 (October 2006) Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies F. Zannad, M. Kessler, P. Lehert, J.P. Grünfeld, C. Thuilliez, A. Leizorovicz, P. Lechat Kidney International Volume 70, Issue 7, Pages 1318-1324 (October 2006) DOI: 10.1038/sj.ki.5001657 Copyright © 2006 International Society of Nephrology Terms and Conditions
Figure 1 Occurrence of primary end point by treatment group. Cox proportional hazard survival adjusted for age and baseline severity. ITT analysis: RR=0.929, P=0.35; per protocol analysis, RR=0.795, P=0.09. X-axis provides time (days) and the corresponding number of at-risk patients. Kidney International 2006 70, 1318-1324DOI: (10.1038/sj.ki.5001657) Copyright © 2006 International Society of Nephrology Terms and Conditions